Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 22.1 Low risk

Quotient, Acesion Partner on AI Drug Development

This partnership highlights the application of AI in medicine for drug development, demonstrating beneficial uses that could contribute to risk mitigation.

This partnership highlights the application of AI in medicine for drug development, demonstrating beneficial uses that could contribute to risk mitigation.

Auto-scored: Event shows positive AI application with no evident risk factors.